個股熱度排行 | 1月24日港股盤前
根據uSMART輿情監測數據，週末期間，市場關注指數最高的5只股票是騰訊控股、比亞迪股份、中遠海能、中海油田服務、復星醫藥。
1月24日—港股關注排行TOP5
騰訊控股
關注度第一爲騰訊控股，該股上個交易日收盤上漲0.68%，報於474.80港元。近5個交易日累計上漲0.30%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
別人家的“年終獎”！騰訊給22800名員工發800萬股，平均每人16.6萬港元
騰訊向超2萬名員工獎勵股票 人均價值16.6萬港元
比亞迪股份
關注度第二爲比亞迪股份，該股上個交易日收盤下跌0.15%，報於260.80港元。近5個交易日累計下跌1.14%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
比亞迪上調新能源車型官方指導價
比亞迪上調部分車價 已簽約客戶維持原價
中遠海能
關注度第三爲中遠海能，該股上個交易日收盤下跌1.59%，報於3.10港元。近5個交易日累計下跌0.64%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
中遠海能：預計2021年度淨虧損49.20億-51.20億元
中遠海能：計提資產減值準備 將減少淨利49.6億元
中海油田服務
關注度第四爲中海油田服務，該股上個交易日收盤下跌2.12%，報於7.38港元。近5個交易日累計下跌3.15%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
中海油田服務預期2021年淨利同比減少87%-91%
中海油田服務計提資產減值準備約20.1億元
復星醫藥
關注度第五爲復星醫藥，該股上個交易日收盤上漲2.82%，報於36.50港元。近5個交易日累計上漲2.53%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
復星醫藥獲MPP新冠口服藥生產許可；思摩爾國際2021年溢利及全面收益總額同比預增109%-131%
復星醫藥：子公司與MPP就新冠口服藥物Molnupiravir授權生產等事宜簽訂分許可協議
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
